Thailand, Cambodia plan border visits for diplomats as violence eases
The ceasefire reached in Malaysia was supposed to take effect at midnight Monday, but it was quickly tested as Thailand and Cambodia continued to accuse each other of violating the truce agreements.
Thailand's Ministry of Foreign Affairs said Thursday it is organising a trip to the border for military attachés of foreign missions and the media on Friday to show the impact of the clashes on the ground.
Cambodia is also organising a border visit for foreign diplomats on the same day. It held a similar trip on Wednesday attended by representatives from 13 countries, including the US and China.
Thailand's government spokesperson Jirayu Houngsub said Thursday that there had been no new clashes reported overnight Wednesday.
But tensions on other fronts continue to simmer. Officials in Thailand's border province of Surin, one of the critical locations of the conflict, on Thursday cautioned evacuees against returning home as they were surveying affected areas for any ammunition that might still pose a risk.
A spokesperson for Cambodia's Defence Ministry, Maly Socheata, said Thursday that Cambodia has received the body of one of its soldiers from Thailand.
'I hope that the Thai Army will return all our soldiers who are currently in the custody of the Thai Army to Cambodia as soon as possible," he said.
Thai foreign minister Maris Sagniampongsa said the Cambodian soldiers were being well taken care of and would be sent back once Thailand is confident they no longer pose a threat. He said security officials would determine when the return would be.
Hun Manet and Thailand's acting prime minister, Phumtham Wechayachai, agreed Monday to an 'unconditional" halt in the fighting, which has killed at least 41 people.
The fighting began last week after a land mine explosion along the border wounded five Thai soldiers.
The peace talks were hosted by Malaysian Prime Minister Anwar Ibrahim, chair of the Association of Southeast Asian Nations. He called the ceasefire a 'vital first step towards de-escalation and the restoration of peace and security." The ceasefire was brokered with US pressure as President Donald Trump said he would not move forward with trade agreements if the conflict continued.
But both countries continued to blame each other, and Thailand accused Cambodia of launching new attacks on Tuesday and Wednesday after the agreement took effect.
Cambodia's Major General Chan Sopheaktra of the Preah Vihear province said Wednesday that the Cambodian military has been strictly adhering to the ceasefire agreement and that there had been two ceasefire violations by Thai forces since the agreement took effect. He did not elaborate on the violations.
Cambodia and Thailand have clashed in the past over their 800-kilometre border.
Tensions had been growing since May, when a Cambodian soldier was killed in a confrontation that created a diplomatic rift and roiled Thailand's domestic politics. (AP) SKS NPK NPK
view comments
First Published:
July 31, 2025, 19:00 IST
News agency-feeds Thailand, Cambodia plan border visits for diplomats as violence eases
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
an hour ago
- First Post
'Ready to resist': Russia blasts Trump over 'unlawful' US tariffs on Global South nations
Russia has described the Trump administration's tariff policies as a 'direct encroachment' on national sovereignty and an 'attempt to interfere' in the internal affairs of other countries read more This combination photo shows President Donald Trump in a business roundtable, May 16, 2025, in Abu Dhabi, United Arab Emirates, left, and Russian President Vladimir Putin at a signing ceremony at the Kremlin in Moscow, May 10, 2025. AP In a sharp rebuke, Russia on Monday (August 4) accused the US of clinging to global dominance through a 'neocolonial' strategy, particularly targeting nations in the Global South with economic pressure. The criticism follows President Donald Trump's recent announcement of new tariffs on countries like India and Russia. Russian Foreign Ministry spokesperson Maria Zakharova stated that the US is grappling with the decline of its global hegemony and resorting to 'politicised economic pressure' against nations that refuse to align with its foreign policy. STORY CONTINUES BELOW THIS AD Zakharova described the Trump administration's tariff policies as a 'direct encroachment' on national sovereignty and an 'attempt to interfere' in the internal affairs of other countries. She warned that such measures threaten global trade and economic stability. Zakharova then reiterated Russia's commitment to fostering a fair and multipolar world order, expressing readiness to collaborate with Global South partners, including BRICS nations and new members like Egypt, Iran, and Indonesia, to counter unilateral sanctions and promote a balanced international system. She also criticised Western 'protectionism,' noting that the imposition of tariffs contradicts the free trade principles once championed by the West. Addressing Washington's tariff policies targeting key Global South partners, Zakharova remarked, 'Sanctions and restrictions have unfortunately become a defining feature of the current historical period, impacting countries across the globe. Unable to accept the erosion of its dominance in an emerging multipolar international order, Washington continues to pursue a neocolonial agenda, employing politically motivated economic pressure against those who choose an independent course on the international stage.' She further elaborated, 'This approach runs counter to the very principles of free trade once championed by Western nations. Instead, we now witness politically driven protectionism and the arbitrary imposition of tariff barriers. Brazil, our strategic partner in Latin America and the Caribbean, is one of the main victims of this policy. Such actions by the United States represent a direct infringement on the sovereignty of other nations and an attempt to interfere in their internal affairs. Beyond these concerns, this policy risks slowing global economic growth, disrupting supply chains, and deepening the fragmentation of the international economic system.' STORY CONTINUES BELOW THIS AD Zakharova underscored Russia's resilience, stating, 'We firmly believe that no tariff wars or sanctions can halt the natural course of history. We are supported by a vast number of partners, like-minded states, and allies, particularly among the countries of the Global South and, above all, within #BRICS, who share this perspective.' She concluded by affirming Russia's readiness to deepen cooperation with these nations to resist 'unlawful unilateral sanctions' and shape a 'genuinely multipolar, just, and equitable international order.' Trump's threat to India The tensions intensified with Trump's latest statement on Monday, posted on Truth Social, where he announced plans to 'substantially raise' tariffs on India for purchasing 'massive amounts of Russian Oil' and selling it on the open market 'for big profits.' Trump claimed India's actions disregard the human cost of the Ukraine conflict, stating, 'They don't care how many people in Ukraine are being killed by the Russian War Machine. Because of this, I will be substantially raising the Tariff paid by India to the USA. Thank you for your attention to this matter!!!' India, in response, staunchly defended its energy policy. The Ministry of External Affairs (MEA) on Monday rejected criticism from the US and the European Union as 'unjustified and unreasonable.' The MEA stressed that India's oil imports from Russia are driven by the need to ensure affordable and predictable energy costs for its consumers, asserting the country's sovereign right to prioritise national interests and economic security. STORY CONTINUES BELOW THIS AD
Hindustan Times
an hour ago
- Hindustan Times
Where is Barron Trump? Tabloid commenter claims, ‘He's lying low, with…'
Barron Trump, the youngest son of President Donald Trump and First Lady Melania Trump, has been absent from events since POTUS' second-term inauguration in January 2025. Barron Trump has taken a backseat since January 2025, focusing on his studies at NYU rather than public appearances. (AP/Rebecca Blackwell) During the 2024 campaign, Trump frequently praised Barron for helping him connect with younger voters. 'He knew the youth vote. We won the youth vote by 36 points. He was saying - 'Dad, you have to go out and do this one or that one'. We did a lot of them. He respects them all, he understood them very well,' the President said at that time. ALSO READ| Where is Barron Trump? Prolonged absence from public life sparks wild rumors about health Barron Trump is simply doing what any 19-year-old would The 6-foot-7-inch strong Trump was occasionally seen at press conferences, campaign stops, and family outings. But since the new term began, Barron has been missing from both official functions and family photo ops. Notably, Donald Jr., Ivanka, and Eric Trump have all been busy attending events, like most recently, President Trump was joined by his sons Donald Jr. and Eric, daughter-in-law Lara, and grandchildren Chloe and Spencer at the opening of Trump International Golf Links in Scotland, but without Barron. This raises the question among many: where is Barron Trump? The Daily Mail report suggests Barron is reportedly settling into college life at New York University and is often spotted around campus or walking the streets of Manhattan. Rumors have swirled online about a new girlfriend, with some social media sleuths sharing speculative posts. 'He's 19yrs old. Things to do. People to meet. Life to lead. Stop trying to turn him into a middle-aged fogey before his time,' one reader wrote in the Daily Mail's comment section. 'He's lying low, with his new girlfriend I think. Must be hard to get the privacy he needs,' another piped in. ALSO READ| What is Barron Trump's NYU Stern tuition cost? For the Trumps, just a drop in a $6 billion ocean Interestingly, the POTUS in May, while discussing the 2026 FIFA World Cup, joked to reporters, 'These events will attract millions of passionate fans around the world, including my son. I have a son that loves soccer – Barron… Nobody's ever heard of Barron, right? Have you ever heard of Barron? He's a good soccer player, too. He's a little tall for soccer, but that's OK.'
Economic Times
3 hours ago
- Economic Times
Trump says he's cut drug prices by up to 1,500%. That's not possible
Synopsis Donald Trump claimed significant drug price cuts, even up to 1500%. Experts refute this, stating such cuts are impossible. They suggest it would mean people are paid to take medicine. The White House defended Trump, citing price differences with other nations. Trump also mentioned future price drops. Some drugmakers are open to cuts. AP Days after he sent letters instructing top pharmaceutical manufacturers to use a "most favored nation" pricing model for prescription drugs, President Donald Trump told reporters on Sunday that he had cut costs by up to 1,500%. But Trump's grandiose claim is mathematically impossible. Here's a closer look at the facts. TRUMP: "You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500%. I don't mean 50%, I mean 14 - 1,500%." THE FACTS: This is false. Cutting drug prices by more than 100% would theoretically mean that people are being paid to take medications. The Trump administration has taken steps to lower prescription drug prices, but experts say there's no indication costs have seen such a massive drop. Geoffrey Joyce, director of health policy at the University of Southern California's Schaeffer Center, called Trump's claim "total fiction" made up by the Republican president. He agreed that it would amount to drug companies paying customers, rather than the other way around. "I find it really difficult to translate those numbers into some actual estimates that patients would see at the pharmacy counter," said Mariana Socal, an associate professor of health policy and management at Johns Hopkins University who studies the U.S. pharmaceutical market. She added that Trump's math is "really hard to follow." Asked what Trump was using to back up his claim, White House spokesman Kush Desai said: "It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people." The White House provided a chart of price differentials for drugs in the U.S. and comparable countries, but did not offer any other evidence. On Sunday, Trump also described cuts to drug prices as a future development, not that already happened. "So we'll be dropping drug prices," he said. "It will start over the next two to three months by 1,200, 1,300 and even 1,400%." Prices for most prescription drugs - unbranded generics are the exception - are higher in the U.S. than they are in other high-income countries. This is in large part due to the way drug prices are negotiated in the United States. Trump made his recent appeal in letters to 17 pharmaceutical manufacturers, the White House announced last week. He asked them to reduce costs in the U.S. by matching the lowest prices of prescriptions drugs in other comparably developed countries. Some drugmakers have since indicated that they are open to cutting costs. This move follows an executive order Trump signed in May setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits in the future over what the government will pay. The federal government has the most power to shape the price it pays for drugs covered by Medicare and Medicaid. It's unclear what - if any - impact the Trump administration's efforts will have on millions of Americans who have private health insurance. Socal pointed out that if drug manufacturers had cut costs to the extent Trump claims, they would be shouting it from the rooftops, especially given the heat they've taken over the years for their pricing practices. "My expectation would be that they would make announcements - public announcements - and that those announcements would come way in advance of the actual effective dates when those price cuts would come into effect," she said. Joyce agreed that there has been no indication of a substantial cut. "Not at all, not at all, none whatsoever," he said. "And let alone 1,500."
